Armistice Capital »

Asml Holding shares owned by Armistice Capital

Quarter-by-quarter ownership of Asml Holding (ASML) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Asml Holding

Tip: Access up to 7 years of quarterly data

All positions including Asml Holding held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Asml Holding by Armistice Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.5M 2.6k 968.09

More positions owned by Armistice Capital

Iwm Nov5 230.0 P Listed Option Put Option (IWM)
Spy Nov5 634.0 P Listed Option Put Option (SPY)
Ptc Therapeutics Ord Equity (PTCT)
Travere Therapeutics Ord Equity (TVTX)
Supernus Pharmaceuticals Ord Equity (SUPN)
Cytk Jan7 40.0 C Listed Option Call Option (CYTK)
Madrigal Pharmaceuticals Ord Equity (MDGL)
Incyte Ord Equity (INCY)
Neurocrine Biosciences Ord Equity (NBIX)
Immunovant Ord Equity (IMVT)
Dentsply Sirona Ord Equity (XRAY)
Regeneron Pharmaceuticals Ord Equity (REGN)
Freshpet Ord Equity (FRPT)
Amazon Com Ord Equity (AMZN)
Agio Dec5 40.0 C Listed Option Call Option (AGIO)

View all positions for Armistice Capital

Top funds holding Asml Holding

Fisher Investments
Capital World Investors
Capital Research and Management Company - Division 3
Susquehanna International
Jpmorgan Chase & Co
State Farm Mutual Automobile Insurance Company
Citadel Advisors
Edgewood Management
Van Eck Associates Corp.
WCM Investment Management
Morgan Stanley
Eagle Capital Management
BlackRock
Jane Street
FMR

View all funds holding Asml Holding